Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Programme Governance

In this section
A close up of a gloved hands holding equipment while carrying out work in a lab.

Programme Oversight

The Novo Nordisk – Oxford Fellowship Programme is overseen by a Joint Steering Committee, which ensures the strategic direction and continued success of the programme. The committee is chaired by Professor Keith Channon (University of Oxford) and co-chaired by Professor Marcus Schindler (Novo Nordisk), with representatives from both partners.

Programme Management

The programme is managed by:

Programme structure and funding

The Radcliffe Department of Medicine coordinates the programme, but fellows have been based across more than ten departments within the Medical Sciences Division (MSD) and the Mathematical, Physical and Life Sciences Division (MPLS) at the University of Oxford.

Since its launch in 2013, the programme has supported over 40 fellows. In 2024, Novo Nordisk committed to funding 20 additional postdoctoral fellowships over the next nine years, bringing the total investment in the programme to £35 million.

Novo Nordisk Members

Oxford Members